Paradigm BioCapital Advisors LP 13D and 13G filings for Oyster Point Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:59 pm Sale |
2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
Paradigm BioCapital Advisors LP | 0 0.000% |
-1,462,576 (Position Closed) |
Filing |
| 2022-07-18 4:24 pm Purchase |
2022-07-07 | 13G | Oyster Point Pharma, Inc. OYST |
Paradigm BioCapital Advisors LP | 1,462,576 5.500% |
1,462,576 (New Position) |
Filing |